Empowering Your Journey to a Healthier You
Wellness Accelerator
Background: Literature evidence suggests that glucagon-like peptide-1 receptor agonists (GLP-1RAs) may have anti-depressant effects. However, population studies assessing the association…
Given the proven benefits of screening to reduce diabetic ketoacidosis (DKA) likelihood at the time of stage 3 type 1…
Scientists are finding that anti-obesity medicines can also help many other diseases The gila monster is a poisonous North American lizard…
Research in mice suggests that blocking, rather than activating the GLP-1 receptor may boost the immune response against colorectal cancer…
The manufacturers of the most popular weight loss drugs are being challengedin court. A federal court in Philadelphia will soon evaluate…
To break into the lucrative weight loss market, Merck will focus on the development of next-generation anti-obesity medications that offer additional cardiometabolic…
GLP-1 agonists were most frequently prescribed to adolescents and adults by endocrinologists and nurse practitioners, respectively. Dispensing of glucagon-like peptide-1…
Background In 2021, about 500 million people were estimated to be living with type 2 diabetes throughout the world. The…
People with type 2 diabetes who are treated with GLP-1 agonists have a decreased risk of developing dementia, according to…
Eli Lilly unleashed a flurry of lawsuits against wellness centers, medical spas and others the pharmaceutical company accused of illegally…
